Search Page

1

Cite

Share

Oncolytic virotherapy: Challenges and solutions.

Goradel NH, Baker AT, Arashkia A, Ebrahimi N, Ghorghanlu S, Negahdari B. Goradel NH, et al. Among authors: baker at. Curr Probl Cancer. 2021 Feb;45(1):100639. doi: 10.1016/j.currproblcancer.2020.100639. Epub 2020 Aug 15. Curr Probl Cancer. 2021. PMID: 32828575 Review.

Cite

Share

2

Cite

Share

To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia.

Othman M, Baker AT, Gupalo E, Elsebaie A, Bliss CM, Rondina MT, Lillicrap D, Parker AL. Othman M, et al. Among authors: baker at. J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23. J Thromb Haemost. 2021. PMID: 34351057 Free PMC article.

Cite

Share

3

Cite

Share

Designer Oncolytic Adenovirus: Coming of Age.

Baker AT, Aguirre-Hernández C, Halldén G, Parker AL. Baker AT, et al. Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201. Cancers (Basel). 2018. PMID: 29904022 Free PMC article. Review.

Cite

Share

4

Cite

Share

Exploring cryo-electron microscopy with molecular dynamics.

Vant JW, Sarkar D, Nguyen J, Baker AT, Vermaas JV, Singharoy A. Vant JW, et al. Among authors: baker at. Biochem Soc Trans. 2022 Feb 28;50(1):569-581. doi: 10.1042/BST20210485. Biochem Soc Trans. 2022. PMID: 35212361 Review.

Cite

Share

5

Cite

Share

ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome.

Baker AT, Boyd RJ, Sarkar D, Teijeira-Crespo A, Chan CK, Bates E, Waraich K, Vant J, Wilson E, Truong CD, Lipka-Lloyd M, Fromme P, Vermaas J, Williams D, Machiesky L, Heurich M, Nagalo BM, Coughlan L, Umlauf S, Chiu PL, Rizkallah PJ, Cohen TS, Parker AL, Singharoy A, Borad MJ. Baker AT, et al. Sci Adv. 2021 Dec 3;7(49):eabl8213. doi: 10.1126/sciadv.abl8213. Epub 2021 Dec 1. Sci Adv. 2021. PMID: 34851659 Free PMC article.

Cite

Share

6

Cite

Share

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.

Uson Junior PLS, DeLeon TT, Bogenberger JM, Pai RK, Kosiorek HE, Yin J, Ahn DH, Sonbol MB, Bekaii-Saab T, Mansfield AS, Buetow K, Gores GJ, Smoot R, Vasmatzis G, Kipp BR, Mahipal A, Baker AT, Babiker H, Barro O, Dumbauld C, Zhou Y, Aslam FN, Barrett M, Jacobs B, Meurice N, Arora M, Petit J, Elliott N, Nagalo B, Salomao MA, Borad MJ. Uson Junior PLS, et al. Among authors: baker at. Dig Dis Sci. 2021 Nov 13. doi: 10.1007/s10620-021-07303-9. Online ahead of print. Dig Dis Sci. 2021. PMID: 34773565

Cite

Share

7

Cite

Share

In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications.

Bates EA, Counsell JR, Alizert S, Baker AT, Suff N, Boyle A, Bradshaw AC, Waddington SN, Nicklin SA, Baker AH, Parker AL. Bates EA, et al. Among authors: baker at. Viruses. 2021 Jul 28;13(8):1483. doi: 10.3390/v13081483. Viruses. 2021. PMID: 34452348 Free PMC article.

Cite

Share

8

Cite

Share

The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry Mechanism.

Baker AT, Davies JA, Bates EA, Moses E, Mundy RM, Marlow G, Cole DK, Bliss CM, Rizkallah PJ, Parker AL. Baker AT, et al. J Virol. 2021 Jan 28;95(4):e01849-20. doi: 10.1128/JVI.01849-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33268514 Free PMC article.

Cite

Share

9

Cite

Share

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications.

Hulin-Curtis SL, Davies JA, Nestić D, Bates EA, Baker AT, Cunliffe TG, Majhen D, Chester JD, Parker AL. Hulin-Curtis SL, et al. Among authors: baker at. Cancer Gene Ther. 2020 Nov;27(10-11):785-798. doi: 10.1038/s41417-019-0156-0. Epub 2020 Jan 6. Cancer Gene Ther. 2020. PMID: 31902944 Free PMC article.

Cite

Share

10

Cite

Share

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers.

Nagalo BM, Breton CA, Zhou Y, Arora M, Bogenberger JM, Barro O, Steele MB, Jenks NJ, Baker AT, Duda DG, Roberts LR, Russell SJ, Peng KW, Borad MJ. Nagalo BM, et al. Among authors: baker at. Mol Ther Oncolytics. 2020 Sep 25;18:546-555. doi: 10.1016/j.omto.2020.08.007. Epub 2020 Aug 19. Mol Ther Oncolytics. 2020. PMID: 32839735 Free PMC article.

Cite

Share